Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Insulin Resistance × licogliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Overweight 1 Obesity 1 Insulin Resistance 1 Hyperandrogenism 1

Interventions

Metformin 5 Pioglitazone 2 ziprasidone 1 salicylsalicylic acid 1 licogliflozin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 cinnulin PF 1 Vitamin D 1 Sugars 1 Sodium Salicylate 1 Resistance Training 1 Olanzapine 1 Leuprolide 1 Flutamide 1 Exercise 1 Ethinyl Estradiol 1 Estrogens 1 Diet Therapy 1 Continuous Positive Airway Pressure 1 Cholecalciferol 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03152591 2021-01-05

PCOS

Novartis

Phase 2 Completed

29 enrolled 24 charts

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡